| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/21/2004 | WO2004009843A3 Detection of microorganisms |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2004001506A3 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 05/21/2004 | WO2003105757A3 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003102215A3 Methods of identifying and isolating stem cells and cancer stem cells |
| 05/21/2004 | WO2003081259A3 Methods of using alpha 1b-adrenergic receptors |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003077851A9 Compounds and methods for analyzing the proteome |
| 05/21/2004 | WO2003072543A3 Methods of preventing or treating brain ischemia or brain injury |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003042395A3 Programmable and autonomous computing machine made of biomolecules |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003013422A3 Methods for the treatment and prognosis of leukemia and other cancer types |
| 05/21/2004 | WO2003012440A3 Method and system for predicting initial analyte values in stored samples |
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002090932A3 Methods and reagents for identifying insulin response modulators and therapeutic uses therefor |
| 05/21/2004 | WO2002088702A8 Dielelectrophoretic method and apparatus for high throughput screening |
| 05/21/2004 | WO2002082045B1 Thin film sensor array for the detection of gases and a method of making |
| 05/21/2004 | WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 05/21/2004 | WO2002071065A8 Immunological detection of prostate diseases and prostasome-related conditions |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002057597A8 Determining the viscosity of a hydrocarbon reservoir fluid |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | CA2545304A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | CA2517580A1 Method of examining cancer cells and reagent therefor |
| 05/21/2004 | CA2506654A1 Method of detecting gene mutation |
| 05/21/2004 | CA2505515A1 Fret probes and methods for detecting interacting molecules |
| 05/21/2004 | CA2505509A1 Method and probes for the detection of a tumor specific fusion protein |
| 05/21/2004 | CA2505507A1 High sensitivity magnetic marker used for immune response measurement |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2504980A1 Method for providing natural therapeutic agents with high therapeutic index |
| 05/21/2004 | CA2504922A1 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 05/21/2004 | CA2504870A1 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 05/21/2004 | CA2504829A1 Diagnostic assay for measuring a cell mediated immune response |
| 05/21/2004 | CA2504593A1 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 05/21/2004 | CA2504481A1 Systems for capture and analysis of biological particles and methods using the systems |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2504334A1 Identifying therapeutic compounds based on their physical-chemical properties |
| 05/21/2004 | CA2504140A1 Semipermeable membrane-based sampling systems |
| 05/21/2004 | CA2504035A1 Amyloid plaque formation by glycosaminoglycans |
| 05/21/2004 | CA2503561A1 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | CA2502580A1 Rapid cell block embedding method and apparatus |
| 05/21/2004 | CA2502413A1 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 05/21/2004 | CA2501786A1 Inhibition of il-17 production |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/21/2004 | CA2486812A1 Substrates, devices, and methods for cellular assays |
| 05/21/2004 | CA2484948A1 Electrical detection of dna hybridization and specific binding events |
| 05/21/2004 | CA2483868A1 Compositions and methods for detection and isolation of phosphorylated molecules |
| 05/21/2004 | CA2483481A1 Method for diagnosing and monitoring cardiac transplant rejection |
| 05/20/2004 | US20040098211 Device for examining liquids |
| 05/20/2004 | US20040098207 System and a method for observing and predicting a physiological state of an animal |
| 05/20/2004 | US20040098202 Method for measuring fluid chemistry in drilling and production operations |
| 05/20/2004 | US20040097829 Tissue biopsy and processing device |
| 05/20/2004 | US20040097822 Process and device for determination of a portion of a component of the air exhaled by a breathing living being characteristic of the metabolic function of such living being |
| 05/20/2004 | US20040097713 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereof |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097527 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 05/20/2004 | US20040097460 Diagnosis of sepsis or SIRS using biomarker profiles |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097422 Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040097409 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096991 Methods for preparing an electrosensor having a capture reagent |
| 05/20/2004 | US20040096990 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 05/20/2004 | US20040096989 Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients |
| 05/20/2004 | US20040096988 Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients |
| 05/20/2004 | US20040096987 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 05/20/2004 | US20040096985 Apparatus for quantitative and qualitative analysis of biopolymers; medical diagnostics |
| 05/20/2004 | US20040096980 Using absorption apparatus to monitor prothrombin activity and blood clotting cascade |
| 05/20/2004 | US20040096979 Polymers for binding of phenols |
| 05/20/2004 | US20040096978 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 05/20/2004 | US20040096977 Particulate processing system |
| 05/20/2004 | US20040096976 Block immobilized om a support; coupling; biosynthesis |
| 05/20/2004 | US20040096965 Activator of fibronectin binding protein and method of its preparation |
| 05/20/2004 | US20040096962 Kit used for fabricating an integrated biomolecule sensor |
| 05/20/2004 | US20040096959 Analyte measurement |
| 05/20/2004 | US20040096957 Apparatus for collecting, testing and monitoring blood glucose levels |
| 05/20/2004 | US20040096953 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same, |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096931 Apparatus which utilizes ultrasonic waves for washing, sanitizing and analyzing bacteria in dispensation injection nozzle |
| 05/20/2004 | US20040096929 Enzymatic cycling assays for homocysteine and cystathionine |
| 05/20/2004 | US20040096928 Biosensor |
| 05/20/2004 | US20040096927 Method for the detection and measurement of biomass |
| 05/20/2004 | US20040096926 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 05/20/2004 | US20040096924 Using enhanced luciferase as reporter molecule to monitor molecular events in biology, biochemistry, immunology and cell biology |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096920 Using immunoglobulins specific for brain natriuretic peptide to diagnose, classify, stratify and prognose mortality rates in patients with congestive heart failure |
| 05/20/2004 | US20040096919 Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| 05/20/2004 | US20040096918 Electrochemiluminescent enzyme immunoassay |
| 05/20/2004 | US20040096917 Nusing hormone, autoantibodies, growth factors, transcription factors, cell surface and/or soluble protein profiles to detect and monitor systemic inflammatory response syndrome |